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other response measures based on validated scales/instruments 7 imputation based on complete score data (following preference 1 to 4 and 6) 8 imputation based on imputation (mostly missing SD) score data (following preference 1 to 4 and 6) 9
other response measure Preference strategy for extraction/imputation of remission data 11 CGI-S = 1 (normal, not ill)/CIDI and other validated diagnostic instrument = no depression) 12 HAMD ≤ 7 (cut-offs ± 1 point accepted) 13 MADRS ≤ 10 (cut-offs ± 1 point accepted) 14 BDI (Beck depression Index) ≤ 8 (cut-offs ± 1 point accepted) 149 CGI-S = 1 or 2 and HAMD cut-off > 9 15-17 if 12 to 14 imputable without problems from score data (as 7) imputation if remission cut-offs clearly higher as stated in 12 to 14 18-20 HAMD, MADRS, BDI with other cut-offs but 15 to 17 not applicable 21 other remission criteria Total events Heterogeneity: Tau² = 0.00; Chi² = 0.47, df = 2 (P = 0.79); I² = 0% Test for overall effect: Z = 2.79 (P = 0.005) Heterogeneity: Tau² = 0.35; Chi² = 7.61, df = 4 (P = 0.11); I² = 47% Test for overall effect: Z = 2.38 (P = 0.02)
TCAs vs. Hypericum
Philipp 1999 Wheatley 1997 Subtotal (95% CI) Total events Heterogeneity: Tau² = 0.00; Chi² = 0.02, df = 1 (P = 0.89); I² = 0% Test for overall effect: Z = 1.78 (P = 0.08) Subtotal (95% CI) Total events Heterogeneity: Tau² = 0.00; Chi² = 1.39, df = 5 (P = 0.92); I² = 0% Test for overall effect: Z = 1.17 (P = 0.24) Beaumont 1984 Blacker 1988 Moon 1988 Richards 1982 Subtotal (95% CI) Total events Heterogeneity: Tau² = 0.47; Chi² = 4.72, df = 2 (P = 0.09); I² = 58% Test for overall effect: Z = 2.42 (P = 0.02) 
SSRI vs. SNRI

SARIs vs. NaSSAs
TCAs vs. placebo
